Maintenance immunosuppression regimens: Conversion, minimization, withdrawal, and avoidance

A wide choice of drug combinations is available to clinicians for immunosuppression regimens for their kidney transplant patients. Although many protocols have minimized early graft loss, the optimal long-term regimen is unknown. Recent studies clearly showed that cardiovascular death is now the leading cause of graft loss. Strategies must be developed that address this risk while keeping immunologic events low. Transplant physicians have focused on exploring regimens that minimize or avoid the use of corticosterolds. Studies also have started to explore protocols that minimize calcineurin Inhibitor therapy.